Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human KIR2DL3 Antikörper:
anti-Mouse (Murine) KIR2DL3 Antikörper:
anti-Monkey KIR2DL3 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal KIR2DL3 Primary Antibody für FACS - ABIN4898680
Ordóñez, Gómez-Lozano, Rosales, Vilches: Molecular characterisation of KIR2DS2*005, a fusion gene associated with a shortened KIR haplotype. in Genes and immunity 2011
Show all 7 Pubmed References
Human Monoclonal KIR2DL3 Primary Antibody für CyTOF, FACS - ABIN4900804
Horowitz, Guethlein, Nemat-Gorgani, Norman, Cooley, Miller, Parham: Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation. in Journal of immunology (Baltimore, Md. : 1950) 2015
Show all 7 Pubmed References
Human Monoclonal KIR2DL3 Primary Antibody für FACS - ABIN4898682
Yu, Mitsui, Wei, Mao, Butchar, Shah, Zhang, Mishra, Alvarez-Breckenridge, Liu, Liu, Yokohama, Trotta, Marcucci, Benson, Loughran, Tridandapani, Caligiuri: NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. in The Journal of clinical investigation 2011
Show all 5 Pubmed References
Human Monoclonal KIR2DL3 Primary Antibody für FACS - ABIN2688999
Cambiaggi, Orengo, Meazza, Sforzini, Tazzari, Lauria, Raspadori, Zambello, Semenzato, Moretta, Ferrini: The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function. in Blood 1996
Show all 4 Pubmed References
Human Monoclonal KIR2DL3 Primary Antibody für FACS - ABIN4898676
Eller, Koehler, Kijak, Eller, Guwatudde, Marovich, Michael, de Souza, Wabwire-Mangen, Robb, Currier, Sandberg: Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif. in Journal of virology 2011
Show all 3 Pubmed References
Human Polyclonal KIR2DL3 Primary Antibody für IF (p), IHC (p) - ABIN748448
Mozer-Lisewska, Mania, Kowala-Piaskowska, Kluk, Samara, Pauli, ?eromski: Detection and significance of cytotoxic cell subsets in biopsies of HCV-infected human livers. in Archivum immunologiae et therapiae experimentalis 2014
Human Monoclonal KIR2DL3 Primary Antibody für FACS, WB - ABIN2478646
Westhof, Flossmann, Müller: The action of ionizing radiation on protein: radical formation in L-histidine crystals. in International journal of radiation biology and related studies in physics, chemistry, and medicine 1975
Show all 2 Pubmed References
The multivariate analysis revealed that the lack of KIR2DS2 (p = 0.035), the presence of KIR2DL3 (p = 0.075), and the presence of KIR2DL2HLA-C1 (p = 0.044) were risk factors for posttransplant cytomegalovirus infection.
These results suggest a detrimental role of HLA-A-Bw4 and HLA-C2 groups, which are associated with the development of chronic hepatitis B, and a protective role of KIR2DL3.
A minority (21%) of HLA-B( *)46:01 peptides, with common C-terminal characteristics, form ligands for KIR2DL3.
KIR 2D (L1, L3, L4, S4) and KIR 3DL1 expression was correlated with poor prognosis in non-small cell lung carcinoma patients.
CD16+ cells were significantly more frequent among Natural Killer (NK) cells negative for the inhibitory KIR (iKIR) KIR2DL1, KIR2DL3, and KIR3DL1 than those positive for any one of these iKIR to the exclusion of the others, making iKIR+ NK cells poorer antibody dependent cellular cytotoxicity effectors than iKIR- NK cells.
These results show that 2DL3(+) NK cells are mediators of HIV-specific responses. Furthermore, responses of NK cell populations to iCD4 are influenced not only by NK cell education through specific KIR/HLA pairs, but also by differential HIV-mediated changes in HLA expression.
Results identified three SNPs (S320F, H245Y, and H77Y) as highly deleterious in KIR2DL3 and nine SNPs (R157Q, H156Y, S63L, R157 W, F179 V, H128R, T101 M, R180C and F176I) in case of IFNL3, in coding region only with high conservation ranks highlighting the functional SNPs on phenotypic variability and disease susceptibility on HCV clearance candidate genes.
KIR2DL2/KIR2DL3-glutamate(35) alleles are functionally stronger than -glutamine(35) alleles.
KIR2DL2/2DS2-C1C1 genotype is associated with type 1 diabetes in Saudi children
gene polymorphism is associated with Crohn's disease in Spanish patients
study compared KIR gene repertoire of HIV-1 positive with exposed uninfected (EU)) infants to elucidate its association with transmission; results revealed presence of significantly high frequencies of activating gene KIR 2DS5 and inhibitory gene KIR 2DL3 in EU infants as compared to HIV-1 positive infants
genetic association study in population in Eastern India: Data suggest that interactions between KIRs (KIR2DL2, KIR2DS4, KIR2DL3) and HLA ligands (HLAC1, HLAC2) contribute significantly toward susceptibility and protection toward type 1 diabetes.
Allelic polymorphism of KIR2DL2/2DL3 in a southern Chinese population.
The authors have identified a deleterious effect of the KIR2DL3-HLA-C1 receptor-ligand combination on HIV clinical outcomes in a Thai cohort.
Single Nucleotide Polymorphism in KIR2DL3 gene is associated with Asthma and Atopic Dermatitis.
KIR2DL3 has previously been identified as important for clearance of the Hepatitis C virus after established infection,not found to be relevant to resistance to Hepatitis C infection.
Genetic risk for co-occurrence of type 1 diabetes and celiac disease is modified by HLA-C and killer immunoglobulin-like receptors.
CD4(+) CD28(-) cells exhibited increased KIR2DS2, reduced KIR2DL3 and increased DAP12 expression in HD-ESRD compared with NDD-CKD patients.
Authors showed an increase in HLA-C1/KIR2DL2 and HLA-C1/KIR2DL3 pairs in human papillomavirus high-risk infected patients (OR 3.05, 3.24) with invasive cervical cancer (OR 1.33, 3.68).
KIR2DL3-positive NK cells were more sensitive to changes in the peptide content of MHC class I than KIR2DL2-positive NK cells.
Receptor on natural killer (NK) cells for HLA-C alleles (HLA-Cw1, HLA-Cw3 and HLA-Cw7). Inhibits the activity of NK cells thus preventing cell lysis.
CD158 antigen-like family member B2
, MHC class I NK cell receptor
, killer cell immunoglobulin-like receptor 2DL3
, killer inhibitory receptor cl 2-3
, natural killer associated transcript 2
, natural killer cell inhibitory receptor KIR2DL3
, natural killer-associated transcript 2
, p58 NK receptor CL-6
, p58 natural killer cell receptor clone CL-6
, p58.2 MHC class-I specific NK receptor
, p58.2 MHC class-I-specific NK receptor